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Abstract
Objective—Nitric oxide (NO) produced by the endothelial NO synthase (eNOS) is an important
regulator of cardiovascular physiology and pathology. eNOS is activated by numerous stimuli and
its activity is tightly regulated. Platelet-endothelial cell adhesion molecule-1 (PECAM-1) has been
implicated in regulating eNOS activity in response to shear stress. The goal of the current study is
to determine the role of PECAM-1 in the regulation of basal eNOS activity.
Methods and Results—We demonstrate that PECAM-1 knockout ECs have increased basal
eNOS activity and NO production. Mechanistically, increased eNOS activity is associated with a
decrease in the inhibitory interaction of eNOS with caveolin-1; impaired subcellular localization
of eNOS; and decreased NOSTRIN expression in the absence of PECAM-1. Furthermore, we
demonstrate that blunted STAT3 activation in the absence of PECAM-1 results in decreased
NOSTRIN expression via direct binding of STAT3 to the NOSTRIN promoter.
Conclusions—Taken together, our results reveal an elegant mechanism of eNOS regulation by
PECAM-1 through STAT3-mediated transcriptional control of NOSTRIN.
Keywords
endothelial cell; eNOS - PECAM-1 - STAT3; NOSTRIN
The production of NO is critical for cardiovascular homeostasis as NO regulates many
fundamental cellular processes, including regulation of vessel tone, cell proliferation, and
angiogenesis1. In the vascular endothelium, NO is synthesized from L-arginine by the
constitutively expressed endothelial nitric oxide synthase (eNOS or NOS3) enzyme. eNOS
function is critical, as genetic deletion of eNOS results in increased blood pressure2, 3,
impaired angiogenesis, abnormal vascular remodeling, and accelerated atherosclerosis4.
Send Correspondence to: Ellie Tzima, PhD, Department of Cell and Molecular Physiology, CB7545, 6341C MBRB, University of





Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2012 March 1.
Published in final edited form as:













Numerous stimuli promote the activation of eNOS through phosphorylation of serine residue
1179, leading to NO production. In this regard, it has been shown that the cell adhesion
molecule PECAM-1 regulates eNOS activation in vitro and in vivo, possibly via a direct
interaction between PECAM-1 and eNOS5, 6. However, the specifics of this interaction are
not known.
eNOS is regulated by multiple interdependent control mechanisms; including post-
translational lipid modifications, phosphorylation, localization and protein-protein
interactions7–9. Together, these regulatory mechanisms ensure proper responses to diverse
stimuli. eNOS is basally repressed through its interaction with an integral membrane protein,
caveolin-1, which inhibits NO production10. In addition, studies show that trafficking and
proper subcellular localization of eNOS are also critical for regulation of its activity10, 11.
There are three pools of eNOS located within the cell: (1) the perinuclear Golgi complex; (2)
the plasma membrane (primarily in caveolae); and (3) a cytosolic compartment. It is
increasingly appreciated that eNOS cantraffic between these compartments and that
subcellular targeting can affect NO production in response to various stimuli12, 13. Recent
studies have identified several eNOS trafficking proteins including NOSIP (eNOS
interacting protein)14 and NOSTRIN (eNOS traffic inducer)12. NOSTRIN is expressed in
ECs both in vitro and in vivo12, 15 and regulates eNOS trafficking and localization12, 15, 16.
Although proteins that influence localization have been identified, the mechanisms that
control eNOS trafficking and the (patho)physiologic consequences are not fully understood.
Here, we investigate the role of PECAM-1 in the regulation of basal eNOS activity. We




PECAM-1−/− C57BL/6 mice were kindly provided by Dr P. Newman (Blood Research
Institute, BloodCenter of Wisconsin, Milwaukee) and eNOS-GFP transgenic mice were
kindly provided by Rini de Crom (Erasmus University Medical Center, Rotterdam, The
Netherlands). All mice were bred in house and used in accordance with the guidelines of the
National Institute of Health and the care and use of laboratory animals (approved by the
Institutional Animal Care and Use Committees of the University of North Carolina at
Chapel Hill). Mice aged 12–16 weeks were used for all experiments.
Cell culture and Reagents
PECAM-1 knockout (PE-KO) cells and cells reconstituted with murine full-length
PECAM-1 (PE-RC) were prepared as described17. HUVECs (Lonza) were grown in M199
media supplemented with EGM2 bullet kit. Cucurbitacin I was purchased from Tocris
Bioscience (Ellsville, Missouri). Antibodies to phospho-Ser1179 eNOS and phospho-Tyr
STAT3 were from Cell Signaling (Danvers, MA). Anti-GM130 was from BD Biosciences
(Transduction, San Diego) and total STAT3 (Santa Cruz, CA) and total GAPDH from
Millipore (Temecula, CA).
Immunoprecipitation and Western Blotting
Cells were harvested in lysis buffer as previously described18. Lysates were assayed by
Western blot. For immunoprecipitation, cells were harvested in OG buffer plus protease
inhibitors19. Equivalent volumes of lysate were pre-cleared with Protein A/G Plus-Agarose
beads (Santa Cruz Biotechnology, Inc) for 1 hour at 4°C. Supernatants were then incubated
with Protein A/G beads previously conjugated with anti-rabbit caveolin-1 (BD
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Transduction). Complexes were washed three times with OG buffer and then assayed by
Western blot.
Immunofluorescence
PE-RC and PE-KO cells were fixed and permeabilized in 3.7% formaldehyde with 0.2%
Triton X-100 for 30 minutes at 37°C then blocked in 1% BSA in PBS for 30 minutes at
37°C. Cells were stained for total eNOS (BD Transduction) and Alexa488-conjugated
Giantin (Covance). Images were taken using either the Zeiss LSM5 Pascal Confocal
microscope using a 63X oil lens. Co-localization was determined using ImageJ and the
thresholded Mander’s colocalization coefficient20. Aorta en face preparations we prepared
as previously described21. En face preparations were evaluated with a Zeiss LSM5 Pascal
microscope.
Cellular Fractionation
Confluent PE-RC and PE-KO cells were fractionated as previously described22. The
samples (25ul) were run on 4–12% SDS-PAGE gels then transferred to nitrocellulose
membrane for Western blot analysis. Membranes were probed with total eNOS, GM130 as a
Golgi marker and caveolin-1 as the plasma membrane marker.
In vitro and in vivo NO Measurements
Cells were serum-starved for 24 hours then treated with either 100mmol/L L-Name, 1μmol/
L ionomycin or L-Name plus ionomycin. Media NO levels were evaluated using the Griess
reagent (NO Assay kit, R&D Systems). PECAM-1 +/+ and −/− animals were anesthetized
using intraperitoneal (IP) injections of ketamine (100mg/kg) and xylazine (15mg/kg) and
injected with 100U heparin. Plasma was isolated for NO measurements, which were
performed using a NO analyzer (Sievers Instruments, Boulder, CO) as previously
described23.
RNA Isolation and Quantitative PCR
Total RNA was isolated from a confluent cell monolayer using the TRIzol reagent
(Invitrogen) and first-strand cDNA was transcribed using random primers and SuperScript II
Reverse Transcriptase (Invitrogen). Real-time quantitative PCR was performed using
ABsolute SYBR Green ROX mix (Thermo Scientific). Relative levels of gene expression
were normalized to mouse 18s expression using the comparative Ct method.
Chromatin Immunoprecipitation (ChIP) Assays
Chromatin immunoprecipitation was performed using the fast ChIP method described by
Nelson et al24 using a rabbit anti-STAT3 K15 antibody (Santa Cruz Biotechnology, Inc).
Quantitative PCR was performed using primers specific for the NOSTRIN promoter.
Quantification and Statistical Analysis
Band intensity of immunoblots was quantified using the ImageJ program. Each experimental
group was analyzed using single factor analysis of variance in Excel (Microsoft). P-values
were obtained by performing two-tailed Student’s t test using Excel. Statistical significance
was defined as P<0.05.
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PECAM-1 regulates basal eNOS activity
Previous studies suggest a requirement for PECAM-1 in shear-induced eNOS activation10,
25, 26. Our own results are in agreement with these observations (data not shown).
Unexpectedly, our data revealed increased levels of phosphorylated eNOS in PECAM-1
knockout (PE-KO) cells compared to PECAM-1 expressing cells (PE-RC) (Figure 1A).
PECAM-1 deletion, however, does not affect total eNOS expression25. To evaluate the
functional consequences of increased basal eNOS phosphorylation in the PE-KO cells, we
measured NO production. As shown in Figure 1B, there is a 3-fold increase in basal NO
production in PE-KO cells compared to PE-RC cells. Stimulation with ionomycin increased
NO production in both cell types, whereas L-NAME inhibited the production of NO. To
determine if these observations are corroborated in whole animals, we measured NO levels
from plasma. Indeed, plasma NO levels were higher in PECAM-1−/− compared to
PECAM-1+/+ animals (Figure 1C).
To further investigate the role of PECAM-1 in regulation of basal eNOS phosphorylation,
we used siRNA to knockdown PECAM-1 expression in human umbilical vein endothelial
cells (HUVECs). The degree of knockdown was assessed by Western blot (Supplemental
Figure IA). Interestingly, we observed an increase in both basal eNOS phosphorylation
(Supplemental Figure IB) and NO production (Supplemental Figure IC) in PECAM-1-
siRNA infected ECs compared to non-specific siRNA control cells. Together, these data
suggest that absence of PECAM-1 results in higher basal eNOS activity and NO production.
Differential association of eNOS and caveolin-1 in the absence of PECAM-1
We next wanted to address the mechanism(s) responsible for the increased basal eNOS
activity in the absence of PECAM-1. To determine if PECAM-1 affects the interaction
between eNOS and known regulatory proteins we performed co-immunoprecipitation
assays. The caveolar scaffolding protein, caveolin-1, has been shown to regulate eNOS
activity, primarily as an inhibitor of basal enzyme function10, 19, 27. Caveolin-1 is able to
bind eNOS and block the calmodulin-binding site important for enzyme activation28. To
determine if PECAM-1 affects the association of eNOS with caveolin-1, we performed co-
immunoprecipitation assays. As shown in Figure 2, there was a decrease in basal eNOS-
caveolin-1 association in the PE-KO cells compared to the PE-RC cells. Additionally,
consistent with the immunoprecipitation data, immunofluorescence confocal analysis also
revealed a slight decrease in the colocalization of eNOS and caveolin-1 in the absence of
PECAM-1 (data not shown). These data suggest that PECAM-1 may regulate basal eNOS
activity by promoting the association of eNOS with caveolin-1.
Role of PECAM-1 in eNOS localization/trafficking
Subcellular localization of eNOS influences its activation11, 13, 23, 29. To determine if
PECAM-1 influences eNOS localization, we performed double-labeling
immunofluorescence confocal microscopy in PE-RC and PE-KO cells. Cells were stained
for total eNOS and giantin, a membrane-inserted component of the cis- and medial-Golgi
complex. In PECAM-1 expressing cells, eNOS is found at both the perinuclear/Golgi
complex and the plasma membrane (PM) (Figure 3A), consistent with the localization
described in blood vessels in vivo30. In contrast, in cells that lack PECAM-1, eNOS is
redistributed away from the perinuclear region (Figure 3A). Indeed, quantitative
colocalization analysis (Mander’s colocalization coefficient) showed decreased
colocalization of eNOS with giantin in the absence of PECAM-1 (Figure 3A). Together,
these data suggest that PECAM-1 influences the subcellular localization of eNOS.
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To further support our in vitro findings, we isolated aortas from PECAM-1+/+ and −/− mice
expressing an eNOS-GFP fusion protein. The aortas were stained en face for giantin and
visualized using confocal microscopy (Figure 3B). Similar to the PE-KO cells, quantitative
colocalization analysis revealed a significant redistribution of eNOS away from the Golgi
complex in the PECAM-1−/− aortas.
As a complementary approach, we utilized sodium carbonate extraction of cells followed by
a discontinuous sucrose gradient. In this procedure, cholesterol-rich microdomains,
including lipid rafts and caveolae, float as buoyant membranes at the 5–30% sucrose
interface (fractions 3–4), whereas soluble proteins and heavy membranes remain at the
bottom of the gradient (fractions 9–11). In all gradients, the distribution of caveolin-1 and
GM130, a Golgi marker, were examined to confirm adequate separation of the fractions
(Figure 3C). In PECAM-1-expressing ECs, eNOS distributed primarily into two distinct
pools: light membranes highly enriched in caveolin-1 and heavy membranes enriched in
GM130. In PE-KO cells, eNOS is also distributed into two pools. However, we noticed a
significant redistribution of eNOS out of the Golgi-enriched fractions (fractions 10–11).
These observations are consistent with the immunofluorescence data described above.
Notably, PE-KO cells have increased eNOS activity and NO levels despite increased
expression levels of the negative regulator caveolin-1 (not shown).
PECAM-1 mediates STAT3-dependent NOSTRIN expression in ECs
eNOS localization is a dynamic and well-coordinated process, mediated by a number of
players including dynamin-2 and NOSTRIN9. To determine if PECAM-1 mediates eNOS
localization through NOSTRIN, we measured NOSTRIN protein expression in PE-RC and
PE-KO cells. Unexpectedly, we observed a significant decrease in NOSTRIN protein
expression in PE-KO cells (Figure 4A). Reduced NOSTRIN expression in PE-KO cells
could be due to either increased protein degradation or a reduction in mRNA levels. To
distinguish between these possible mechanisms, we first measured ubiquitination of
NOSTRIN but did not observe a difference between the PE-RC and PE-KO cells (data not
shown). Next, we used quantitative real-time PCR to determine the effect of PECAM-1
deletion on NOSTRIN mRNA levels. Our data demonstrate that NOSTRIN mRNA is
significantly decreased in the absence of PECAM-1 (Figure 4B).
We next addressed the mechanism by which PECAM-1 affects NOSTRIN protein
expression. It has previously been shown that the cytoplasmic tail of PECAM-1 is able to
function as a scaffold for numerous signaling pathways, including signal transducers and
activators of transcription (STAT) protein family members STAT5 and STAT331, 32.
Additionally, ECs isolated from PECAM-1−/− mice have reduced STAT3
phosphorylation32. We asked whether the reduced levels of active STAT3 in the PECAM-1
knockout might result in decreased NOSTRIN expression. To determine if STAT3
phosphorylation is reduced in cells that lack PECAM-1, we probed PE-KO cell extracts for
total STAT3 and phospho-STAT3. Importantly, our data are in agreement with previous
reports showing that phospho-STAT3 levels are lower in the absence of PECAM-1 (Figure
5A). To determine if STAT3 activity affects NOSTRIN expression, we treated the
PECAM-1 expressing ECs with cucurbitacin, a selective inhibitor of STAT3/JAK signaling,
and assayed for changes in NOSTRIN expression by Western blot and quantitative real-time
PCR. Interestingly, cucurbitacin treatment results in a dose-dependent decrease in both
NOSTRIN protein expression (Figure 5B) and mRNA levels (Figure 5C). These results
suggest that PECAM-1 mediates STAT3-induced NOSTRIN expression, which, in turn,
regulates eNOS localization.
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Binding of STAT3 to the NOSTRIN promoter in endothelial cells
Analysis of the NOSTRIN promoter revealed several putative STAT3 binding sites
(Supplemental Table I). STAT family members bind to a conserved sequence of TT and AA
duplicates typically separated by 5 bases. In addition to binding TT(N5)AA nanomers,
STAT3 is also able to bind octomers and decamers33, 34. We next investigated the
possibility that STAT3 directly binds to the NOSTRIN promoter to modulate mRNA
expression by chromatin immunoprecipitation (ChIP) assays with STAT3 antibodies.
Immunoprecipitation of the chromatin lysates was followed by PCR with NOSTRIN
promoter primers; NOSTRIN exon 10 primers served as a control. ChIP assays show that
STAT3 binds to the NOSTRIN promoter region, but not the NOSTRIN coding region
(Figure 5D). Together, these data suggest that STAT3 may regulate NOSTRIN mRNA
levels by specifically binding to the NOSTRIN promoter.
Discussion
Understanding the mechanisms that regulate NO production in the endothelium can provide
important insight into processes that initiate endothelial dysfunction and lead to the
development of atherosclerosis. NO production is dynamically regulated by a number of
humoral and mechanical factors. In this study, we investigated PECAM-1 regulation of
basal eNOS activity. An unexpected finding of this study was the increased basal eNOS
activity and NO production in PE-KO cells as well as PECAM-1−/− mice. An attractive
hypothesis to explain the basal regulation of eNOS by PECAM-1 is their reported physical
association. However, reports of this interaction have been highly conflicting. One group
showed that shear stress induces a transient increase in the association of PECAM-1 and
eNOS6, while other studies have shown just the opposite5. Our own results suggest only a
weak basal association of eNOS and PECAM-1 in static ECs (data not shown). In addition,
ultra-structural and biochemical analyses suggest that eNOS resides within caveolae10, 35,
whereas PECAM-1 is found at a membrane network just below the plasmalemma at the cell
borders that is distinct from caveolae36. Furthermore, studies in HUVECs have shown no
colocalization between PECAM-1 and caveolin-1 and that these two proteins do not co-
migrate on sucrose gels36. The lack of physical association between eNOS and PECAM-1
led us to investigate differences in eNOS protein interactions and localization as possible
mechanisms of regulation.
It is well recognized that correct subcellular targeting of eNOS is critical for proper
regulation of its activity and NO bioavailability; thus, tight control of eNOS targeting to
different compartments appears to be essential. In this regard, our data point towards a
requirement for tightly regulated levels of NOSTRIN expression within ECs.
Overexpression of NOSTRIN can promote the translocation of eNOS from the plasma
membrane to intracellular vesicles, with a concomitant reduction in eNOS enzyme
activity12. Conversely, decreased NOSTRIN expression also influences eNOS subcellular
localization and may contribute to the increased NO levels observed in the PECAM-1
knockout. Interestingly, overexpression of the eNOS-binding partner, caveolin-1, leads to
accelerated atherosclerosis formation in mice, partially through reduced NO production37;
while persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary
hypertension38. Thus, tight regulation of eNOS regulatory protein levels, including
NOSTRIN and caveolin-1 expression, is required for proper eNOS function.
Here, we present exciting data to support a novel mechanism of eNOS regulation by
PECAM-1. Our current working model is summarized in Figure 6. The cytoplasmic tail of
PECAM-1 acts as a scaffold for STAT3 and mediates its activation. A possible candidate for
the activation of STAT3 are the Src-family kinases, as Src-mediated STAT activation has
been previously reported39, 40. Following activation, STAT3 dimerizes and translocates into
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the nucleus where it modulates expression of gene targets, including NOSTRIN. Once
expressed, NOSTRIN facilitates eNOS trafficking and its correct subcellular localization. It
is possible that the reduced NOSTRIN levels account for the difference in eNOS-caveolin-1
association, however this could be due to other undetermined mechanisms. Of note, it has
been reported that eNOS, caveolin-1 and NOSTRIN form a ternary complex to facilitate
eNOS translocation16. Additionally, our data are consistent with the hypothesis that
NOSTRIN might serve to stabilize the inhibitory effect of caveolin-1 on eNOS16.
The signaling pathway identified here relates to the regulation of basal eNOS activity via
PECAM-1. However, PECAM-1 is also known to regulate eNOS activation in response to
the physiologic stimulus of shear stress5, 6, 25, 41. PE-KO cells are unable to activate eNOS
in response to shear stress, yet they activate eNOS in response to ionomycin, indicating a
specific requirement for PECAM-1 in flow-induced eNOS activation (Figure 1B and
Supplemental Figure II). It is worth noting here that PECAM-1 is also required for flow-
induced activation of Akt and Src, two important upstream mediators of eNOS activity25, 41.
The role of shear stress in NOSTRIN-mediated eNOS regulation is currently under
investigation.
Blood flow and the NO signaling pathway are both known modulators of cardiovascular
development and physiology. Two recent studies have provided compelling evidence for an
evolutionarily conserved, shear-stress- and NO-mediated pathway that also regulates
hematopoiesis42–44. PECAM-1is thought to be involved in flow mechanosensing, based on
in vitro and in vivo experiments showing PECAM-1-dependentactivation of flow-mediated
intracellular signaling pathways and vascular remodeling6, 45, 46. Interestingly, PECAM-1 is
required for NO-mediated dilation in response to shear stress in isolated skeletal muscle
arterioles41 as well as in the mouse coronary circulation47, thus underscoring the importance
of both PECAM-1 and NO in flow-mediated remodeling. Previous studies have also
identified the importance of eNOS in flow-mediated remodeling48. We now reveal a
sophisticated dual mode of eNOS regulation by PECAM-1; while PECAM-1−/− ECs are
unable to activate eNOS in response to shear stress, their basal eNOS activity and NO levels
are, paradoxically, increased through STAT3-mediated transcriptional control of NOSTRIN.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Basal eNOS phosphorylation and NO production in the PECAM-1 KO. A, PE-KO cells
have increased basal peNOS compared to PE-RC (n=6, *P<0.005). B, PE-RC and PE-KO
cells were treated with 1mmol/L L-Name or 1μmol/L ionomycin and NO levels measured
(n=3, *P<0.01 vs PE-RC basal). C, Plasma levels of NO from PECAM-1 +/+ and −/− mice
were assayed as described. (n=7 mice;*P<0.05 vs PECAM-1 +/+).
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Differential association of the negative eNOS-binding partner, caveolin-1, in the absence of
PECAM-1. PE-RC and PE-KO cells were immunoprecipitated using an antibody against
Cav1. Western blots were performed for total eNOS and Cav1. Quantitation is shown on the
right (n=6; *P<0.001 vs PE-RC).
McCormick et al. Page 12














PECAM-1 regulates eNOS subcellular localization. A, PE-RC and PE-KO cells stained for
total eNOS (red) and Giantin (green). Colocalization was determined using the thresholded
Mander’s coefficient (n=4, 25 cells/experiment; *P<0.05). B, En face aortas from eNOS-
GFP/PECAM-1 +/+ or −/− mice stained for Giantin (red) (50 cells/genotype; *P<0.05). C,
Subcellular fractionation of PE-RC and PE-KO cells. Fractions were immunoblotted for
total eNOS, GM130 and Cav-1 (n=3, *P<0.05). Bar = 5μm.
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Reduced NOSTRIN expression in ECs lacking PECAM-1 A, Levels of NOSTRIN protein
were measured in PE-RC and PE-KO cells by Western Blot. GAPDH was measured for
loading (n=4, *P<0.001 vs PE-RC). B, Real-time PCR analysis revealed decreased
NOSTRIN mRNA levels in PE-KO cells (n=5, *P<0.001 vs PE-RC).
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PECAM-1 regulates NOSTRIN in a STAT3-dependent manner. A, Western blot for
phosphorylated STAT3 in PE-RC and PE-KO cells. Quantitation shown on right (n=3,
P<0.01 vs PE-RC). B, PE-RC and PE-KO cells treated for 24 hours with 0.5, 5 and 20μmol/
L cucurbitacin then lysed and NOSTRIN protein expression determined by Western Blot.
Values normalized to GAPDH (n=3, *P<0.05). C, Real-time PCR analysis of NOSTRIN
mRNA expression in PE-RC cells treated for 12hrs with cucurbitacin. (n=3, *P<0.001). D.
ChIP on PE-RC cells for STAT3 binding to NOSTRIN promoter region.
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Model of PECAM-1-mediated NOSTRIN expression and eNOS trafficking. The
cytoplasmic tail of PECAM-1 acts as a scaffold for STAT3 binding. Following activation,
STAT3 translocates to the nucleus where it regulates NOSTRIN mRNA expression.
NOSTRIN protein is then able to bind eNOS and regulate its trafficking and localization
with the cell.
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